
    
      Subjects will be admitted to the site one day before each study drug administration (i.e. Day
      -1) and confined at the site till the collection of post-dose PK samples (Day 21). For
      subjects with hepatic impairment, subject will discharge on Day 21, and will visit the
      clinical unit on Day 24 (±1 day) and Day 28 (±1 day) for collection of post-dose PK samples.
      End of study Visit For Healthy subjects will take place 1 to 5 days following collection of
      last PK sample.
    
  